Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • News

Reported Late Tuesday, New York Selects Forian’s Biotrack As The State’s Cannabis Seed To Sale Track And Trace System

By Benzinga Newsdesk
December 21, 1:53 AM
Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced that New York has selected BioTrack as the track and trace

FORA

Read More
1 minute read
  • Earnings
  • News

Forian Q3 EPS $(0.16) Beats $(0.17) Estimate, Sales $7.18M Beat $6.67M Estimate

By Benzinga Newsdesk
November 14, 5:30 PM
Forian (NASDAQ:FORA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 27.27 percent increase over losses of $(0.22) per share from the same

FORA

Read More
17 minute read
  • Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights
November 14, 6:06 AM
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday

By Lisa Levin
September 19, 1:53 AM
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

AAOI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

BLAZE Receives SOC 1 Certification

By Vuk Zdinjak
August 17, 9:55 AM
Cannabis software company BLAZE Solutions, Inc. validated its data performance and implementation and gained SOC 1 Certification.

FORA

Read More
1 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Forian Q2 Revenue Grows 44% YoY, Here Are The Details

By Vuk Zdinjak
August 12, 9:12 AM
Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022. Q2 2022 Financial Highlights

FORA

Read More
1 minute read
  • Earnings
  • News

Forian Q2 Sales $6.50M Beat $6.18M Estimate

By Benzinga Newsdesk
August 11, 4:30 PM
Forian (NASDAQ:FORA) reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.18 million by 5.18 percent. This is a 42.92 percent increase over sales of $4.55 million the same period

FORA

Read More
17 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook

Earnings Scheduled For August 11, 2022

By Benzinga Insights
August 11, 5:09 AM
  Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

Read More
22 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook

Earnings Scheduled For August 9, 2022

By Benzinga Insights
August 9, 5:02 AM
  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

AAIC

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

ScottsMiracle-Gro, TerrAscend, Canopy Growth & Other Large Cannabis Stocks Announce Earnings Release Dates

By Vuk Zdinjak
July 22, 11:44 AM
Several large cannabis companies and cannabis related companies, announced earnings report release dates this week.

CGC

Posts pagination

Previous 1 2 3
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service